[Auto-immune hypoglycemic syndrome induced by pyritinol].
The auto-immune hypoglycemic syndrome is characterized by the association of hypoglycemia (clinical and/or biological) and anti-insulin antibodies in patients who have never received exogenous insulin. Initially this syndrome was most often described in Japanese patients some of whom were treated with drugs containing a sulfydril group. We now recall the case of a female caucasian patient treated with Pyritinol for rhumatoid polyarthritis and who presented severe spontaneous hypoglycemia linked with the presence of anti-insulin antibodies in her serum. The level of her antibodies decreased abruptly on suspension of the drug. The recent and more developed characterization techniques of the different forms of circulating insulin and of their antibodies may help to differenciate an auto-immune hypoglycemia from hypoglycemia due to the secret auto-administration of bovine and porcine insuline, and permit us to suggest that an abnormality in the structure of the molecule of insulin might be a cause of this syndrome. However, the exact mechanism of hypoglycemia linked with the presence of anti-insulin auto-antibodies is not yet clear as is the predisposition of a drug with a sulfydril group to induce such an auto-immune phenomenon.
Faguer de Moustier
B
B
Clinique de Diabétologie, Hôtel-Dieu, Paris.
Burgard
M
M
Boitard
C
C
Desplanque
N
N
Fanjoux
J
J
Tchobroutsky
G
G
D000368:Aged; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D001327:Autoimmune Diseases / Q000209:etiology*; D005260:Female; D006801:Humans; D007003:Hypoglycemia / Q000209:etiology*; D007328:Insulin / Q000097:blood; D007330:Insulin Antibodies / Q000032:analysis; D011725:Pyridines / Q000009:adverse effects*; D011746:Pyrithioxin / Q000009:adverse effects* / Q000627:therapeutic use; D013577:Syndrome
D007328:Insulin; D007330:Insulin Antibodies; D011725:Pyridines; D011746:Pyrithioxin
Syndrome hypoglycémique auto-immun induit par le pyritinol.